catalpol has been researched along with Polycystic Ovary Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Z; Nie, X; Tan, Y; Wang, F; Yan, J; Zhao, J; Zhou, G; Zhou, Y | 1 |
1 other study(ies) available for catalpol and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Catalpol attenuates polycystic ovarian syndrome by regulating sirtuin 1 mediated NF-κB signaling pathway.
Topics: Animals; Estradiol; Female; Granulosa Cells; Humans; Iridoid Glucosides; NF-kappa B; Polycystic Ovary Syndrome; Progesterone; Rats; Signal Transduction; Sirtuin 1; Testosterone | 2022 |